In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Innospec Inc. trades 30.6% below its PERT-weighted fair value of $110.01, indicating potential undervaluation with high confidence from diverse methods. However, Monte Carlo analysis shows high volatility (74.28% CV) and a 55.6% chance of downside below the current price, reflecting elevated investment risk. Financial health scores reveal strong liquidity and leverage but modest growth and profitability, signaling balanced opportunity versus risk.